SS
ALT icon

SBI Securities’s Altimmune ALT Stock Holding History

SBI Securities’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.5K Sell
8,062
-251
-3% -$750 ﹤0.01% 1472
2026
Q1 		$25.6K Sell
8,313
-524
-6% -$2.23K ﹤0.01% 1359
2025
Q4 		$31.9K Buy
8,837
+1,928
+28% +$8.4K ﹤0.01% 1262
2025
Q3 		$26K Sell
6,909
-209
-3% -$807 ﹤0.01% 1341
2025
Q2 		$27.5K Buy
7,118
+364
+5% +$1.97K ﹤0.01% 1285
2025
Q1 		$33.8K Buy
6,754
+549
+9% +$3.48K ﹤0.01% 1130
2024
Q4 		$44.7K Buy
+6,205
New +$47.4K ﹤0.01% 1022

Other funds holding ALT

HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
BWCS
Beirne Wealth Consulting Services Shelton, Connecticut $503M AUM 27.98% 1-Year Est. Return
BWM
Brown Wealth Management Naperville, Illinois $447M AUM 16.94% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
SFWA
Summit Financial Wealth Advisors Lafayette, Louisiana $782M AUM 24.35% 1-Year Est. Return
KWA
Kingswood Wealth Advisors San Diego, California $2.48B AUM 36.19% 1-Year Est. Return
PAM
PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return
LSA
Leonteq Securities AG Zurich, Switzerland $2.91B AUM 56.5% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

SBI Securities's ALT Position: Q2 2026 in Review

SBI Securities reduced its Altimmune (ALT) stake by 3% in Q2 2026, selling an estimated $750 and leaving 8,062 shares worth $24.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1472.

SBI Securities first reported a position in ALT in Q4 2024 and has held it in 7 quarters since. The position peaked at $44.7K in Q4 2024. 38 funds tracked by Wall St. Rank hold ALT as of Q2 2026.

  • SBI Securities held 8,062 shares of Altimmune worth $24.5K as of Q2 2026.
  • SBI Securities sold 251 Altimmune shares in Q2 2026, an estimated $750.
  • Altimmune made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #1472 holding.
  • SBI Securities first reported a position in Altimmune in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Altimmune position peaked at $44.7K in Q4 2024.
  • 38 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.